June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Interleukin-7 and -15 Maintain Memory T Helper 17 Cells in Dry Eye Disease
Author Affiliations & Notes
  • Yihe Chen
    Schepens Eye Research Ins /MEEI, Boston, Massachusetts, United States
  • Sunil Chauhan
    Schepens Eye Research Ins /MEEI, Boston, Massachusetts, United States
  • xuhua tan
    Schepens Eye Research Ins /MEEI, Boston, Massachusetts, United States
  • Reza Dana
    Schepens Eye Research Ins /MEEI, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Yihe Chen, Schepens Eye Research Institute (P); Sunil Chauhan, Schepens Eye Research Institute (P); xuhua tan, None; Reza Dana, Schepens Eye Research Institute (P)
  • Footnotes
    Support  NIH R01 EY 20889
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 551. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yihe Chen, Sunil Chauhan, xuhua tan, Reza Dana; Interleukin-7 and -15 Maintain Memory T Helper 17 Cells in Dry Eye Disease. Invest. Ophthalmol. Vis. Sci. 2017;58(8):551.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : Memory T helper 17 (mTh17) cells have been found crucial in mediating the chronicity of various refractory autoimmune disorders, including dry eye disease (DED); however, the underlying mechanisms maintaining mTh17 cells have remained elusive. This study was designed to investigate whether interleukin (IL)-7 and IL-15 maintain mTh17 cells in chronic DED.

Methods : Chronic DED was induced by exposing C57BL/6 mice to desiccating stress using a controlled environment chamber for 14 days and then housing mice in a standard environment for additional 14 days. Expression of IL-7 receptor (IL-7R) and IL-15 receptor (IL-15R) by mTh17 cells (CD4+CD44hiIL-17A+) derived from chronic DED mice was analyzed using flow cytometry. IL-7 and IL-15 mRNA and protein expressions in DED mice were quantified by real-time PCR and ELISA. In addition, draining lymph nodes isolated from chronic DED mice were cultured in the presence of IL-7, IL-15, IL-7 and IL-15, anti-IL-7 antibody (Ab), anti-IL-15 Ab, anti-IL-7 and anti-IL-15 Abs, or control IgG for 72 hours, and then examined for the frequencies of mTh17 cells using flow cytometry. Finally, therapeutic effects of topical neutralization of either IL-7, IL-15 or IL-17 were evaluated in chronic DED.

Results : mTh17 cells from chronic DED mice expressed IL-7R and IL-15R. IL-7 and IL-15 expression was significantly higher in chronic DED mice compared to normal mice at both mRNA (2-fold increase, p < 0.05) and protein (37.3±6.2 and 99.2±14.3, vs. 2.0±0.3 and 43.1±4.8, p < 0.05) levels in the conjunctiva. They were constitutively expressed at comparable levels in the DLNs of normal and DED mice. Furthermore, DLNs from chronic DED mice cultured in the presence of IL-7, IL-15, or IL-7 and IL-15 together, displayed higher frequencies of mTh17 cells (0.20±0.03%, 0.18±0.02%, 0.16±0.02%, respectively) compared with those cultured with anti-IL-7 Ab (0.057±0.002%), anti-IL-15 Ab (0.055±0.017%), anti-IL-7 and anti-IL-15 Abs together (0.081±0.006%), or control IgG (0.087±0.006%). Topical neutralization of ocular IL-7 or IL-15 effectively reduced DED severity and significantly suppressed frequencies of mTh17 cells in both conjunctiva and DLN, while topical neutralization of IL-17 did not affect mTh17 frequencies in the DLN.

Conclusions : These findings demonstrate that both IL-7 and IL-15 maintain mTh17 cells and could serve as novel therapeutic targets for chronic DED.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.